I’m behind on vaccine injury research. I’ve come to find the topic very depressing, and we all already know what’s going on. Still, this is still the plague chronicle, and I owe you at least brief remarks on these developments.
This Swiss study on sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 booster vaccination has already made the rounds on John Campbell’s YouTube channel and at friend-of-the-blog Alex Berenson’s substack. The authors looked at troponin T levels in 777 employees of the University Hospital Basel three days after receiving the Moderna booster jab. While there were no anomalous ECG results and no major adverse cardiac events in study participants, one in 35 of the 69.5% female cohort showed evidence of cardiac injury. Twenty of these injuries occurred in women, and two in men. While many prior studies have found that serious cases are concentrated in young males, it seems that milder vaccine-induced myocarditis may be more common in women. Moderna is the highest-dosed and therefore the most dangerous Covid vaccine on the market, and it just boggles the mind that it is still on offer to anyone, let alone the young and healthy.
Berenson has also covered the nationwide Korean study on COVID-19 vaccination-related myocarditis. It’s a retrospective analysis that only looks at the most severe hospitalised cases and deaths, necessarily overlooking milder injuries. Of 21 vaccine-related myocarditis deaths, eight were identified only upon autopsy, and all of these were in Koreans aged 45 or younger. These easily overlooked stealth cases comprise a solid majority of the 12 myocarditis deaths in this age group. I will go out on a limb and suggest that these are people who developed post-vaccination subclinical heart injuries of the kind detected in the Swiss study, and then died suddenly, probably during exercise or some other kind of exertion. The vaccines are super safe and super effective and super cool and nobody cares about the fact that they cause high rates of totally-transient-not-a-big-deal-bro cardiac problems in young people.
Finally, there is this older Scandinavian study on clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries from back in December. The authors look at all 7,292 myocarditis diagnoses which occurred in Denmark, Finland, Norway and Sweden between 2018 and mid- late-2022. 530 or 7.3% of these were a side-effect of Covid vaccination, and 109 or 1.5% were associated with Covid infection; the remaining 6,653 (91.2%) were baseline myocarditis cases.
Over 56% of the relatively few Covid-associated myocarditis cases were aged 40 or older, while 64% of the vaccine-induced cases were aged 39 or younger (38% in the 12–24 age group). The authors conclude, optimistically, that “Compared with myocarditis associated with COVID-19 disease and conventional myocarditis, myocarditis after vaccination with SARS-CoV-2 mRNA vaccines was associated with better clinical outcomes within 90 days of admission to hospital.” I find this to be not very comforting, as vaccine-induced myocarditis is concentrated in young healthy people, while other myocarditis is concentrated in older and sicker groups.